Feature | September 10, 2014

Authors Say Contrast-Enhanced CT Safe for Most Patients

Authors Say Contrast-Enhanced CT Safe for Most Patients

September 10, 2014 — According to new research performed at the Mayo Clinic, iodine-based contrast material injected intravenously to enhance computed tomography (CT) images can be safely used in most patients. The study appears online in the journal Radiology.

Of the 80 million or more CT scans performed each year in the United States, iodine-based contrast material is used in at least half to enhance CT images, according to researcher Robert J. McDonald, M.D., Ph.D., a radiology resident at the Mayo Clinic in Rochester, Minn.

According to McDonald, a small number of case reports from the 1950s and, more recently, retrospective studies lacking appropriate control groups causally linked the use of iodine-based contrast CTs to kidney damage, a condition called contrast-induced nephropathy.

“For nearly 60 years, physicians have worried about contrast-induced nephropathy when using iodinated contrast material, particularly for patients with impaired kidney function,” McDonald said. “Emerging evidence now suggests these concerns are likely vastly overestimated.”

McDonald and a team of researchers analyzed information on patients who underwent abdominal, pelvic and thoracic CT scans at the Mayo Clinic between 2000 and 2010. A study group of 21,346 patients included 10,673 patients who each underwent a contrast-enhanced CT exam and 10,673 patients who underwent a similar CT without intravenous contrast. The two groups were closely matched by demographic and clinical characteristics, including gender, race and pre-existing conditions such as diabetes, congestive heart failure and acute renal disease.

The researchers analyzed the patient data for adverse events following the CT scans, including acute kidney injury, the need for emergency renal dialysis (in patients with no prior history of dialysis) and death within 30 days of contrast exposure.

The analysis revealed no significant difference in the rate of acute kidney injury between patients in the contrast group (4.8 percent, or 515 of 10,673) and the non-contrast group (5.1 percent or 544 of 10,673). More importantly, the rates of emergency dialysis and death in the 30-day window following CT examination were not significantly different between patients exposed to contrast and those who were not exposed. These results were also observed among patients with compromised kidney function and high-risk conditions, such as congestive heart failure and diabetes, which are assumed to predispose a patient to kidney injury.

“These results challenge long-held assumptions regarding the presumed nephrotoxic risk of intravenous contrast material,” McDonald said. “We hope that our findings will help refine the safety profile of these contrast agents."

For more information: www.radiologyinfo.org

Related Content

New Study Evaluates Head CT Examinations and Patient Complexity
News | Neuro Imaging | May 17, 2019
Computed tomography (CT) of the head uses special X-ray equipment to help assess head injuries, dizziness and other...
FDA Clears Aidoc's AI Solution for Flagging Pulmonary Embolism
Technology | Artificial Intelligence | May 15, 2019
Artificial intelligence (AI) solutions provider Aidoc has been granted U.S. Food and Drug Administration (FDA)...
Gorilla Undergoes Follow-up CT Scan at Boston's Franklin Park Zoo

Gigi, a western lowland gorilla at Fanklin Park Zoo (Boston), recently underwent a computed tomography (CT) scan as part of efforts to identify the cause of ongoing health issues in recent months. Image courtesy of Zoo New England

News | Computed Tomography (CT) | May 06, 2019
Gigi, a western lowland gorilla, was recently put under anesthesia at Franklin Park Zoo (Boston) so the zoo’s...
Aidoc Raises $27 Million in Series B Funding
News | Artificial Intelligence | May 02, 2019
Radiology artificial intelligence (AI) solutions provider Aidoc announced a $27 million investment, bringing its total...
Canon Medical Installs First CT Scanner With AI in Belgium
News | Computed Tomography (CT) | May 02, 2019
May 2, 2019 — Canon Medical has installed the Aquilion One Genesis, one of the first...
Physicians, Patients Talking Less About Lung Cancer Screening
News | Lung Cancer | April 29, 2019
Smoking rates are down nationally, but so are discussions among physicians and smokers about lung cancer screening,...
ITN Wins Jesse H. Neal Award for Best Technical Content
News | Radiology Business | April 24, 2019
April 24, 2019 — Imaging Technology News (ITN) was recently named the 2019 Jesse H.
Video Plus Brochure Helps Patients Make Lung Cancer Scan Decision

Image courtesy of the American Thoracic Society

News | Lung Cancer | April 19, 2019
A short video describing the potential benefits and risks of low-dose computed tomography (CT) screening for lung...
FDA Clears GE's Deep Learning Image Reconstruction Engine
Technology | Computed Tomography (CT) | April 19, 2019
GE Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) of its Deep Learning Image...